Hikma Pharmaceutical | HIK - Stock


Hikma Pharmaceutical reported $1.11B in Stock for its fiscal semester ending in December of 2025.





Stock Change Date
Almirall EUR 178.13M 1.54M Dec/2025
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.93B 362M Jun/2026
Autolus Therapeutics Ltd USD 33.23M 24K Mar/2026
Bayer EUR 12.01B 321M Mar/2026
Fresenius EUR 2.73B 119M Mar/2026
Genmab DKK 21M 8M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.78B 220M Mar/2026
Orion EUR 512.2M 55.9M Mar/2026
Recordati EUR 550.34M 4.52M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024